Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
AI use in schools: How districts are making sure it's used as a study aid
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Gelesis Holdings, Inc.
Gelesis’ Oral Treatment for Weight Management Showed Real-World Effectiveness in New Data Presented at the American Diabetes Association’s Annual Conference
June 26, 2023
From
Gelesis Holdings, Inc.
Via
Business Wire
Gelesis Reports Fourth Quarter and Full Year 2022 Results
March 28, 2023
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis to Participate in the 25th Annual ICR Conference
January 05, 2023
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference
November 21, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance
November 18, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Reports Third Quarter 2022 Results
November 14, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance
November 04, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to Prebiotics
November 02, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week
November 01, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
August 25, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Reports Second Quarter 2022 Results
August 15, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022
August 04, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million
June 21, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Over the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study
June 05, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Microbiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel
June 04, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis to Participate in Upcoming Investor Conferences
May 18, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis Reports First Quarter 2022 Results
May 12, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
May 09, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes
May 04, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
April 29, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook
March 24, 2022
From
Gelesis Holdings, Inc.
Via
Business Wire
Tickers
GLS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.